High throughput screening of physicochemical properties and in vitro ADME profiling in drug discovery.
about
Interpreting physicochemical experimental data sets.The performance of 1-ethyl-3-methylimidazolium tetrafluoroborate ionic liquid as mobile phase additive in HPLC-based lipophilicity assessment.Characterization of interactions between methoxatin disodium salt and human serum albumin by pressure-assisted capillary electrophoresis/frontal analysis and circular dichroism spectroscopy.A novel strategy for the targeted analysis of protein and peptide metabolitesStructure-Based Drug Design of Mineralocorticoid Receptor Antagonists to Explore Oxosteroid Receptor Selectivity.Physiologically based pharmacokinetic models: integration of in silico approaches with micro cell culture analogues.Recent development in high-throughput bioanalytical support for in vitro ADMET profiling.An integrated bioanalytical platform for supporting high-throughput serum protein binding screening.Recent development in software and automation tools for high-throughput discovery bioanalysis.A method for measuring the lipophilicity of compounds in mixtures of 10.Novel Acoustic Loading of a Mass Spectrometer: Toward Next-Generation High-Throughput MS Screening.Time dependent analysis of assay comparability: a novel approach to understand intra- and inter-site variability over time.Maximizing the outcome of early ADMET models: strategies to win the drug-hunting battles?A novel LC-MS approach for the detection of metabolites in DMPK studies.Cassette incubation followed by bioanalysis using high-resolution MS for in vitro ADME screening assays.High-throughput quantitation of large molecules using multiplexed chromatography and high-resolution/accurate mass LC–MS
P2860
Q30967921-B7AE83A9-1BF8-4A8C-9EC2-469640AB6A6AQ33673038-0C869338-A4C9-4142-88F3-9D00AA0879F2Q35172118-6A5D8779-1402-470A-8B8F-42BCDBA1A1EEQ36112076-C9F0FF10-7394-4358-9783-41F9877CBDDCQ36206559-A89E01CF-8BC3-4E4B-AC04-8391034A8BF3Q37665888-87129657-2479-486C-8A5F-CF6D5196D7CAQ37693962-AB0221D3-C320-48BE-B86F-006190B86508Q37809834-7A87BD2A-6BCE-4550-9524-2FF9077A2321Q38011790-6F9C02F0-2F31-4BA3-9C34-D468B95D681EQ39779913-F1C39F72-75EC-4063-B99B-F1239490FBDCQ40153758-AE8D607A-861F-4E76-9CA1-0E06C5518756Q41387262-5E496033-A050-41FE-AFF1-64BB7E0C8B51Q42694829-9446D822-FEDE-4EED-9C98-7A4C31C3439DQ42806954-4D4B53F7-7B05-47C3-B33E-6DD6A874F871Q44033985-EC6EE21D-8055-4543-A644-44FE8A188C79Q56561163-1907BC44-ED3C-40DF-BF97-5E06BB133A82
P2860
High throughput screening of physicochemical properties and in vitro ADME profiling in drug discovery.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
High throughput screening of p ...... E profiling in drug discovery.
@ast
High throughput screening of p ...... E profiling in drug discovery.
@en
type
label
High throughput screening of p ...... E profiling in drug discovery.
@ast
High throughput screening of p ...... E profiling in drug discovery.
@en
prefLabel
High throughput screening of p ...... E profiling in drug discovery.
@ast
High throughput screening of p ...... E profiling in drug discovery.
@en
P1476
High throughput screening of p ...... E profiling in drug discovery.
@en
P2093
Anders G Holmén
P304
P356
10.2174/138620709787581701
P577
2009-03-01T00:00:00Z